JPMorgan reveals stocks worth buying in October 2026
JPMorgan added five stocks to its Overweight list, highlighting American Express (AXP) as a Value pick, Thermo Fisher (TMO) and Liberty Energy (LBRT) as Growth picks. AXP is down 18-19% YTD but JPMorgan sees steady profits and share buybacks. TMO is up 25% in 3 months, with growth driven by partnerships and AI-powered lab machines. LBRT is up 52% in 12 months, benefiting from AI data center power demands.
How this was made

The 30-second read
Why it matters
The new recommendations provide fresh analyst endorsement, likely prompting short‑term buying pressure on the named stocks.
Market read
Analyst overweight designations can move small‑cap stocks and influence sector sentiment, especially in AI‑related themes.
What to watch
Potential credit risk for AXP and commodity price exposure for LBRT could temper enthusiasm.
Background
JPMorgan released its latest Overweight list, adding three stocks as top picks for value and growth strategies.
Ticker impact
JPMorgan added American Express as its main Value pick in the new Overweight list, indicating a fresh analyst endorsement.
likely upward pressure as the stock gains attention from the new overweight rating
Analyst overweight adds credibility and may trigger buying from JPMorgan‑following funds.
Thermo Fisher was highlighted as a Growth pick, with JPMorgan noting a partnership with Mayo Clinic and AI‑lab machine potential.
likely upward pressure as investors price in the growth narrative
The analyst’s bullish comments and partnership highlight new revenue avenues.
Liberty Energy was named a Growth pick tied to AI data‑center power demand, with JPMorgan citing a multi‑year demand runway.
likely upward pressure as the stock benefits from the analyst’s AI‑power thesis
Analyst focus on a niche growth theme can attract capital to a small‑cap name.
Market effects
Highlights a shift toward AI‑related energy and biotech growth themes, potentially lifting related sector ETFs.
U.S. equities may see modest gains in financial and industrial sectors as analysts adjust weightings.
Limited to U.S. markets; no immediate global macro impact.
Counterpoint
Some investors may view the picks as overvalued given recent price runs and could be cautious.
Key entities
- financial_institutionJPMorgan Chase
Issuer of the Overweight list and analyst recommendations.
- companyAmerican Express
Credit‑card issuer highlighted as a Value pick.
- companyThermo Fisher Scientific
Biotech equipment supplier highlighted as a Growth pick.
- companyLiberty Energy
Energy firm highlighted for AI‑data‑center power demand.


